NRXS vs. GUTS, ICCM, VANI, APT, TMDIF, CTSO, APYX, INO, MODD, and NXL
Should you be buying NeurAxis stock or one of its competitors? The main competitors of NeurAxis include Fractyl Health (GUTS), IceCure Medical (ICCM), Vivani Medical (VANI), Alpha Pro Tech (APT), Titan Medical (TMDIF), Cytosorbents (CTSO), Apyx Medical (APYX), Inovio Pharmaceuticals (INO), Modular Medical (MODD), and Nexalin Technology (NXL). These companies are all part of the "medical equipment" industry.
NeurAxis vs.
NeurAxis (NASDAQ:NRXS) and Fractyl Health (NASDAQ:GUTS) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their earnings, community ranking, profitability, analyst recommendations, media sentiment, dividends, institutional ownership, valuation and risk.
Fractyl Health received 3 more outperform votes than NeurAxis when rated by MarketBeat users.
NeurAxis has a net margin of -492.76% compared to Fractyl Health's net margin of -64,849.48%.
NeurAxis has higher revenue and earnings than Fractyl Health. NeurAxis is trading at a lower price-to-earnings ratio than Fractyl Health, indicating that it is currently the more affordable of the two stocks.
Fractyl Health has a consensus price target of $18.00, indicating a potential upside of 1,167.61%. Given Fractyl Health's stronger consensus rating and higher possible upside, analysts plainly believe Fractyl Health is more favorable than NeurAxis.
11.8% of NeurAxis shares are owned by institutional investors. 15.2% of NeurAxis shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.
In the previous week, NeurAxis and NeurAxis both had 1 articles in the media. Fractyl Health's average media sentiment score of 1.86 beat NeurAxis' score of 0.00 indicating that Fractyl Health is being referred to more favorably in the news media.
Summary
Fractyl Health beats NeurAxis on 8 of the 14 factors compared between the two stocks.
Get NeurAxis News Delivered to You Automatically
Sign up to receive the latest news and ratings for NRXS and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
NeurAxis Competitors List
Related Companies and Tools
This page (NASDAQ:NRXS) was last updated on 2/22/2025 by MarketBeat.com Staff
Free NRXS Stock Alerts